Testosterone Replacement Therapy and the Risk of Hypoglycemia
We report the case of a 45-year-old man with a history of Klinefelter syndrome undergoing testosterone replacement therapy, and with type 2 diabetes treated with metformin with poor metabolic control. When vildagliptin was added to his treatment, he presented hypoglycemia after the testosterone inje...
Saved in:
| Main Authors: | Analía Verónica Yamaguchi, Pablo René Costanzo, Verónica Andrea Peuchot, Pablo Knoblovits |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2019/9616125 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Testosterone Replacement Therapy
by: Wayne J.G. Hellstrom
Published: (2004-01-01) -
El hipogonadismo masculino en pacientes con diabetes tipo 2
by: Pablo Knoblovits, et al.
Published: (2025-03-01) -
Management of Adverse Effects in Testosterone Replacement Therapy
by: Basheer Basheer, et al.
Published: (2025-04-01) -
Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement Therapy
by: Prasanth N. Surampudi, et al.
Published: (2012-01-01) -
Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
by: Ali Atan, et al.
Published: (2013-01-01)